Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study (STT-CLIPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02091921|
Recruitment Status : Completed
First Posted : March 19, 2014
Results First Posted : June 19, 2019
Last Update Posted : June 19, 2019
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Screening|
Critical Limb Ischemia
|Recruitment Details||Patients with diagnosis of CLI (Rutherford class IV, V and VI) on continuous dual antiplatelet therapy with clopidogrel 75 mg and aspirin 81 mg daily for at least 14+2 days|
A total of 53 patients consented and enrolled the study. 3 patients were excluded from the study and did not complete the study; one developed a skin reaction after the first IP dose; the other two due to events unrelated to the study (Pneumonia and Rheumatoid arthritis pericarditis).
50 Patients completed the study.